Francisco Javier
Blanco García
Catedrático de Universidade
University of Copenhagen
Copenhague, DinamarcaPublications in collaboration with researchers from University of Copenhagen (2)
2019
-
A Phase II Trial of Lutikizumab, an Anti–Interleukin-1α/β Dual Variable Domain Immunoglobulin, in Knee Osteoarthritis Patients With Synovitis
Arthritis and Rheumatology, Vol. 71, Núm. 7, pp. 1056-1069